Markers of bone metabolism in children with rickets

The problem of rickets remains relevant due to the widespread prevalence of the disease and unsatisfactory results of diagnosis and treatment.

Objective. To identify changes in the biochemical parameters of bone metabolism and to establish their relationship with the clinical condition of children with rickets.

Materials and methods. The authors conducted a simultaneous controlled clinical comparative study of 108 children aged from 5 months to 2 years. C-terminal telopeptide of type I collagen (CrossLaps), calcitriol, calcitonin, osteocalcin, and blood osteoprote-gerin were analyzed by the enzyme-linked immunosorbent assay method. The level of calcium was determined by colorimetric method, phosphorus — by photometric test. Alkaline phosphatase activity was evaluated in blood serum by an optimized kinetic method.

Results. We determined a decrease in the level of serum calcitriol, calcitonin, calcium and phosphorus, as well as an increase in the concentration of the C-terminal telopeptide of type I collagen, osteocalcin, parathyroid hormone, osteoprotegerin, acid and alkaline phosphatase activity. The greatest increase in the level of osteoprotegerin was recorded in children with the II degree of rickets, both in acute and subacute course. The concentration of osteocalcin was increased in all groups of patients with the highest values in patients with the II degree of rickets, regardless of the course of the disease. The activity of acid phosphatase in the blood of patients was also increased. A decrease in the concentration of calcitriol, calcitonin, calcium and phosphorus in the blood was observed in all groups of children with rickets.

Conclusion. The authors recorded the correlations between the studied indicators of bone metabolism in patients with rickets. An increase in the level of osteoprotegerin is apparently a new link in the pathogenesis of rickets.

1. Maylyan E.A., Reznichenko N.A., May-lyan D.E. Association of polymorphism of the genes of the vitamin D system with certain human diseases. Vyatskii med-itsinskii vestnik 2017; 2(54) 30—40. (in Russ.)

2. National program “Vitamin D deficiency in children and adolescents of the Russian Federation: modern approaches to correction”. Union of Pediatricians of Russia. Moscow: Pediatr, 2018; 96. (in Russ.)

3. Acar S., Demir K., Shi Y. Genetic causes of rickets. J Clin Res Pediatr Endocrinol 2017; 9(2): 88-105. DOI: 10.4274/jcrpe.2017.S008

4. Vlasova A.N., Gaymolenko I.N., Tikhonenko O.A. Application of vitamin D in often sick children. Zabaikal’skii meditsinskii vestnik 2014; 2: 92—95. (in Russ.)

5. Zakharova I.N., Korovina N.A., Dmitrieva Yu.A. Modern view on the pathogenesis and prevention of rickets. Praktika pediatra 2012; 2: 34—40. (in Russ.).

6. HolickM.F., Grant W.B. Vitamin D status and ill health. Lancet Diabetes Endocrinol 2014; 2(4): 273—274. DOI: 10.1016/S2213-8587(13)70165-7

7. Maltsev S.V., Arkhipova N.N., Shakiro-va E.M. Vitamin D, calcium and phosphate in healthy children and with pathology. Kazan, 2012; 15. (in Russ.)

8. Reusheva S.V., Panicheva E.A., Pastukhova S.Yu., Reushev M.Yu. The importance of vitamin D deficiency in the development of human diseases. Uspekhi sovremennogo estestvoznaniya 2013; 11: 27—31. (in Russ.)

9. Donnikov A.E., Bordakova E.V., Smetnik A.A., Yakushevskaya O.V., TrofimovD.Yu., Yurene-va S.V. Clinical and prognostic value of molecular-genetic factors in postmenopausal osteoporosis. Osteoporoz i oste-opatii 2016; 2: 34. (in Russ.)

10. Pankratova Yu.V., Pigaro-va E.A., Dzeranova L.K. Vitamin K-dependent proteins: osteocalcin, matrix GLA protein and their extracostal effects. Ozhirenie i metabolizm 2013; 2 (35): 11—18. (in Russ.)

11. Pavlov S.B. Participation of parathyroid hormone and calcitonin in the regulation of bone metabolism in modeling its disorders. Vestnik problem biologii i meditsiny 2013; 1(2): 185—189. (in Russ.)

12. Danilov N.V. Osteoporosis as a problem of thyroid surgery. Nauka molodyh — Eruditio Juvenium 2014; 1: 105—113. (in Russ.)

13. Zaharov I.S., KolpinskijG.I., Ushakova G.A., Vavin G.V. Biochemical markers in the diagnosis of bone remodeling disorders in osteoporosis. Vestnik Avicenny 2013; 4(57): 119—123. (in Russ.)

14. Kiselyova I.V. Changes in markers of bone metabolism in blood serum in patients with osteoporosis. Sovremennye problemy nauki i obrazovaniya 2014; 3: 552. (in Russ.)

15. Kochetkova E.A., Burya K.A., Ugaj L.G., Kocyurbij E.A., Nevzorova V.A., Luk’yanov P.A., Albavichus S.A. The role of osteoprotegerin in the formation of osteopenic syndrome in chronic obstructive pulmonary disease. Tihookeanskii meditsinskii zhurnal 2013; 1: 20—22. (in Russ.)

16. Gershtejn E.S., Timofeev Yu.S., Zuev A.A., Kushlinskij N.E. Ligand-receptor system RANK/RANKL/OPG and its role in primary bone neoplasms (literature analysis and own results). Uspekhi molekulyarnoi biologii 2015; 2(3): 51—59. (in Russ.)